Abstracts Archive - Page 35 of 1683 - ATC Abstracts

2022 American Transplant Congress
Investigating RNA Interference-Mediated Inhibition of Liver Ischemia Reperfusion Injury During Liver Preservation
J. E. Buchwald¹, D. Echeverria², J. Sousa², N. McHugh², A. Khvorova², P. N. Martins³
¹RNA Therapeutics Institute, Department of Surgery, University of Massachusetts Chan Medical School, Worcester, MA, ²RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, ³Department of Surgery, University of Massachusetts Chan Medical School, Worcester, MA
*Purpose: Liver transplantation cures acute end-stage and chronic liver diseases, yet current strategies of organ preservation including static cold storage (SCS) and machine perfusion (MP)…
2022 American Transplant Congress
Incidence of Delayed Graft Function in Kidneys Recovered After Normothermic Regional Perfusion
L. James¹, M. D'Angelo¹, J. Carillo¹, J. C. Berger¹, D. E. Smith¹, N. Moazami¹, B. Lonze²
¹NYU Langone Health, New York, NY, ²NYU Langone Transplant Institute, New York, NY
*Purpose: The use of normothermic reperfusion (NRP) following donation after circulatory death (DCD) is an emerging strategy for organ procurement. NRP technique reestablishes circulatory blood…
2022 American Transplant Congress
Semaglutide Tolerability and Efficacy in Patients with Chronic Kidney Disease Stage 4, 5 and End Stage Renal Disease
J. J. Long, A. Lemke, V. Sudhindran, N. Pencovici, A. Kukla, T. Diwan
Mayo Clinic, Rochester, MN
*Purpose: Obesity is often a barrier to kidney transplantation (KT) due to increased perioperative risks and worse outcomes with many transplant centers setting BMI cut…
2022 American Transplant Congress
Nebulized Mitochondria Localize to Transplanted Allografts and Improve Outcomes Following Lung Transplantation
D. Nord¹, Z. Tu², L. Langerude¹, A. McQuiston¹, J. Kwon³, S. Nadig⁴, T. Machuca⁵, C. Atkinson¹
¹Pulmonary Medicine, University of Florida, Gainesville, FL, ²University of Florida, Gaineville, FL, ³MUSC College of Medicine, Charleston, SC, ⁴Northwestern University, Charleston, SC, ⁵Department of Surgery, University of Florida, Gainesville, FL
*Purpose: Mitochondrial transplantation therapy is an innovative strategy for the treatment of mitochondrial dysfunction. The approach has shown efficacy in the treatment of cardiac ischemic…
2022 American Transplant Congress
Why and How We Do Native Nephrectomy in Low Weight Pediatric Kidney Transplantation Patients
N. Celik¹, B. Akyollu¹, E. Arpali¹, N. Akinci², I. Bilge², B. Kocak¹
¹Division of Organ Transplantation, Koc University Hospital, Istanbul, Turkey, ²Division of Pediatric Nephrology, Koc University Hospital, Istanbul, Turkey
*Purpose: There is no consensus about optimal timing for native nephrectomy according to the primary indication of kidney transplantation (KTx) especially in pediatric population and…
2022 American Transplant Congress
Donor Terminal Creatinine – Does It Matter?
V. G. Menon, Y. Wert, W. Hoffman, D. Ladie, M. Singh, M. Waybill, H. Yang
UPMC, Harrisburg, PA
*Purpose: When assessing deceased donor kidneys, the transplantation team studies several donor variables including creatinine. A creatinine that is elevated immediately prior to procurement can…
2022 American Transplant Congress
Baseline Findings from the UREAACT Trial to Improve Medication Adherence in Youth with Kidney Transplants
S. Amaral¹, P. Kwong², J. Zhu², R. George³, N. Rodig⁴, B. Warady⁵, J. Smith⁶, A. Bobrowski⁷, D. Matossian⁸, N. Zelikovsky⁹, L. Schwartz¹, P. Reese², R. Goldfarb Terry¹, J. Reason², A. Chung¹, S. Furth¹
¹CHOP, Phila, PA, ²UPenn, Phila, PA, ³CHOA, Atlanta, GA, ⁴Boston Children's, Boston, MA, ⁵Children's Mercy, Kansas City, MO, ⁶Seattle Children's, Seattle, WA, ⁷Cleveland Clinic, Cleveland, OH, ⁸Lurie Children's, Chicago, IL, ⁹LaSalle Univ, Phila, PA
*Purpose: This abstract describes the design and baseline characteristics of participants in the U-REAACT trial, a study to improve medication adherence in youth with kidney…
2022 American Transplant Congress
Single Center Retrospective Study Examining the Safety of the New Potassium- Binders for Post-Operative Hyperkalemia in Kidney Transplant Recipients
S. Kapoor¹, A. Campbell², Y. Azzi¹, L. E. Liriano-Ward³, T. Shertel⁴, W. Xiao⁵, D. U. Nnani⁶, S. Farghaly¹, S. Yun⁷, E. Akalin¹, M. Ajaimy¹
¹Einstein-Montefiore Transplant Center, Bronx, NY, ²Montefiore Medical Center, Bronx, NY, ³Transplant, Montefiore Medical Center, Bronx, NY, ⁴-, -, AL, ⁵Albert Einstein College of Medicine, Folsom, CA, ⁶Pharmacy, Montefiore Medical Center, Bronx, NY, ⁷Montefiore Medical Center, New York, NY
*Purpose: We aimed to evaluate the safety and efficacy of two potassium-binders (Patiromer and Sodium Zirconium Cyclosilicate (SZC) in early post-transplant hyperkalemia treatment of kidney…
2022 American Transplant Congress
Hold the Opioids Please: Long-Term Outcomes Following an Opioid Minimization Protocol in Kidney Transplantation
T. Carcella, N. Patel, J. Marable, J. Fleming, P. Baliga, D. Dubay, S. Bethi, D. Taber, V. Rohan
Medical University of South Carolina, Charleston, SC
*Purpose: Opioid use following kidney transplantation (KTX) is associated with an increased risk of graft loss and mortality. Opioid minimization strategies and protocols have demonstrated…
2022 American Transplant Congress
Outcomes After Kidney Transplantation in Post Bariatric Surgery Patients: Systematic Review 
N. Pencovici¹, J. Long¹, M. Stegall², A. Kukla¹, T. Diwan¹
¹Mayo Clinic Rochester, Rochester, MN, ²Mayo Clinic, Rochester, MN
*Purpose: Morbid obesity is a barrier to kidney transplantation (KT) due to increased perioperative risks and worse outcomes. Bariatric surgery (BS) is increasingly performed in…